WayPoint Biomedical Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WYPH research report →
Price Chart
About the company
WayPoint Biomedical Holdings, Inc. , through its wholly owned subsidiary, WayPoint Biomedical, Inc. , engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment.
- CEO
- Steven Fox
- IPO
- 2015
- Employees
- 1
- HQ
- Huntington Beach, CA, US
Get TickerSpark's AI analysis on WYPH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $19.94K
- P/E
- -3.40
- PEG
- -0.03
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -2.04
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 0.00%
- ROIC
- 0.00%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-44,976
- Net Income
- $-44,976+0.0%
- EPS
- $-0.00+0.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -1.06
- RSI (14)
- 69
- Avg Volume
- 1.08K
No earnings-call transcripts are available for WYPH yet.
- Free Float
- 0.0%
- Shares Outstanding
- 33.24M
- Float Shares
- 0
Our WYPH coverage
Recent articles, reports, and earnings notes.
No research on WYPH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate WYPH report →